Endoscopic Devices - South Africa

Revenue in the Endoscopic Devices market market in South Africa is projected to reach US$175.40m in 2024.
Revenue is expected to demonstrate an annual growth rate (CAGR 2024-2029) of 6.33%, which will result in a market volume of US$238.30m by 2029.
In a global context, the highest revenue is anticipated to be generated the United States, with a figure of US$10.39bn in 2024.
In South Africa, the endoscopic devices market is experiencing significant growth driven by increasing healthcare investments and a rising demand for minimally invasive surgical procedures.

Definition:
The Endoscopic Devices market, a medical technology market, includes the sale of endoscopic devices. Endoscopy involves the use of an endoscope to examine the inside of a hollow organ or body cavity. The market includes various types of endoscopes, such as gastroscopes, laparoscopes, bronchoscopes, and colonoscopes.

Additional information:
Market values represent revenues paid to primary vendors at manufacturer price level either directly or through distribution channels (excluding VAT). Reported market revenues include spending by consumers (B2C), enterprises (B2B), and governments (B2G). Revenues are allocated to the country where the money is spent.

Key players in the market include Olympus Corporation, Boston Scientific Corporation, and Stryker Corporation. Further information on the key players can be found in the Market Shares boxes.

Endoscopic devices
Implants such as stents

pharmaceuticals for endoscopic procedure

The Endoscopic Devices Market in South Africa is experiencing moderate growth, influenced by factors such as advancements in minimally invasive procedures, increasing healthcare investments, and rising demand for diagnostic and therapeutic solutions among healthcare providers.

Customer preferences: In South Africa, there is a growing preference for advanced endoscopic procedures as patients and healthcare providers alike prioritize less invasive treatment options that promise quicker recovery times and reduced hospital stays. This shift is influenced by a more informed population seeking personalized healthcare solutions, alongside an increasing awareness of the benefits of early diagnosis. Additionally, the rise of private healthcare investments is fostering innovation in endoscopic technologies, catering to the demand for improved patient outcomes and overall healthcare efficiency.

Trends in the market: In South Africa, the Endoscopic Devices Market is experiencing a surge in demand for minimally invasive surgical techniques, driven by patient preference for shorter recovery times and reduced hospital stays. Furthermore, healthcare providers are increasingly adopting advanced endoscopic technologies to enhance diagnostic accuracy and treatment efficacy. The trend is supported by rising healthcare investments, which are fostering innovation in device development. This shift not only improves patient outcomes but also poses significant implications for industry stakeholders, including manufacturers and healthcare providers, who must adapt to evolving market dynamics and patient expectations.

Local special circumstances: In South Africa, the Endoscopic Devices Market is shaped by unique local factors such as a diverse population with varying health needs and a mix of public and private healthcare systems. The country's geographic disparities affect healthcare access, prompting a demand for mobile endoscopic units in rural areas. Culturally, there is an increasing emphasis on patient-centered care, encouraging healthcare providers to adopt innovative technologies. Regulatory frameworks are evolving to support rapid approval processes for new devices, further stimulating market growth and enhancing treatment accessibility.

Underlying macroeconomic factors: The Endoscopic Devices Market in South Africa is significantly influenced by macroeconomic factors such as overall economic stability, healthcare funding, and investment in medical technology. The country's economic growth, albeit modest, has led to increased public and private healthcare spending, enhancing the accessibility of advanced medical devices. Additionally, favorable fiscal policies aimed at improving healthcare infrastructure are encouraging local and foreign investment in endoscopic technologies. Global trends, such as the rising prevalence of gastrointestinal disorders and a growing focus on minimally invasive procedures, further bolster market demand, while regulatory advancements streamline the approval of innovative devices, ultimately improving patient outcomes.

Data coverage:

Data encompasses B2B, B2G, and B2C spend. Figures are based on medical devices and IVD revenues allocated to the country where the money is spent at manufacturer price levels excluding VAT.

Modeling approach / Market size:

Modeling employs a top-down approach with a bottom-up validation, using financial information of the key players by market. Market sizes are determined by a top-down approach, based on a specific rationale for each market market and allocated to the covered countries according to the global market shares. As a basis for evaluating markets, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per capita, health risk factors, healthcare system, and regulations concerning medical products. Next, we use further relevant key market indicators and data from country-specific associations, such as healthcare expenditure per capita, health risk factors, healthcare payer system, and regulations concerning medical products. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level.

This report presents a comprehensive analysis and additional information on the Health market, in a PDF format.

Medical technology plays a role in the lives of everyone. It includes most of all, medical devices which simplify the prevention, diagnosis, and treatment of diseases and illnesses. The most well-known medical technology products are, among others, pacemakers, imaging instruments, dialysis machines, and implants. The global medical technology industry was worth over 567 billion U.S. dollars annually. Established centers of this industry include North America and Western Europe. The United States is home to the world’s largest medical technology companies. As of 2022, Abbott Laboratories had the largest global revenue at over 31.2 billion U.S. dollars. The main focus of devices manufactured by the Chicago-based company are diagnostics, cardiovascular, and diabetes care. Two other medtech companies that round off the top three largest companies –Medtronic and Johnson & Johnson – are both based in the United States. Although, industry trends show that Asia, and in particular China, is about to play a more prominent role in the years to come.